Moderna saves the world from COVID. Is it time to buy her shares

So far, Moderna's only commercial product is a CORONAVIRUS vaccine, and the company's revenue largely depends on its success. What this means for her shares

What does the company do

Industry : Biotechnology
Ticker : MRNA
Capitalization : $ 98.96B
P/E : 197.16
P/S : 123.17
July 14 Price : $246.45
Consensus Estimate : $177

Moderna is a pharmaceutical company focused on the discovery and development of messenger RNA (mRNA) therapies.

Read together with it: